UPLOAD Filing
Contineum Therapeutics, Inc.
Date: May 20, 2025 · CIK: 0001855175 · Accession: 0000000000-25-005357
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287275
Letter
Re: Contineum Therapeutics, Inc. Registration Statement on Form S-3 Filed May 14, 2025 File No. 333-287275 Dear Carmine Stengone:
May 20, 2025
Carmine Stengone Chief Executive Officer Contineum Therapeutics, Inc. 3565 General Atomics Court, Suite 200 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeffrey C. Thacker, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 20, 2025 Carmine Stengone Chief Executive Officer Contineum Therapeutics, Inc. 3565 General Atomics Court, Suite 200 San Diego, CA 92121 Re: Contineum Therapeutics, Inc. Registration Statement on Form S-3 Filed May 14, 2025 File No. 333-287275 Dear Carmine Stengone: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey C. Thacker, Esq. </TEXT> </DOCUMENT>